Triac Trial II in MCT8 Deficiency Patients

Clinical trial NCT02396459 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02396459
Sponsor: Rare Thyroid Therapeutics International AB
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Allan-Herndon-Dudley Syndrome

Start date: 2020-12-07
Primary completion: 2027-07-18
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.